SpringWorks Therapeutics, Inc. - common stock (SWTX) analyst actions
Rating and price-target actions on SWTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SWTX overview →
1 measured SWTX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN | Press release | -0.82% | -2.95% |
Keep exploring
More SWTX: earnings → · SEC filings → · SWTX overview →